20086 ā
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients; Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
Sub-classes:SOLID PHARMACEUTICAL FORMULATION OF PARP INHIBITORS AND USE THEREOF
#2SOLID PHARMACEUTICAL FORMULATION OF PARP INHIBITORS AND USE THEREOF
#3TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#4COMPOSITIONS AND METHODS FOR MAKING AND USING SMALL MOLECULES FOR TUBULIN-TARGETED THERAPY IN THE TREATMENT OF CANCERS AND RELATED CONDITIONS
#53Alpha-OH-5Alpha-Pregnan-20-One Compositions and Methods for Treating CNS Disorders
#6OPHTHALMIC COMPOSITIONS AND METHODS FOR SUSTAINED DRUG RELEASE
#7ORAL DELIVERY FORMULATIONS USING SELF EMULSIFYING GRANULES AND LIPID BASED GRANULES
#8FORMULATIONS OF TEGAVIVINT
#9AMORPHOUS SOLID DISPERSIONS
#10SPRAY-DRIED AMORPHOUS SOLID DISPERSIONS AND METHOD FOR PREPARATION
#11COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#12LIPID MICROBUBBLE LYOPHILIZED POWDER COMPOSITION AND PREPARATION METHOD THEREOF
#13Cannabidiol Solid Dosage Forms
#14POWDER MIXTURE COMPRISING REPARIXIN
#15LUBRICANT
#16WATER-SOLUBLE CANNABIDIOL COMPOSITIONS AND METHOD FOR PREPARATION OF WATER-SOLUBLE CANNABIDIOL
#17PHARMACEUTICAL COMPOSITIONS OF TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITOR AND METHODS FOR MAKING SAME
#18TAMPER RESISTANT DOSAGE FORMS
#19AMORPHOUS SOLID DISPERSIONS
#20BONDED MICROPARTICULATES PREPARATION AND APPLICATIONS THEREOF
#21COMPOSITIONS COMPRISING AMINO ACID ADDUCTS AND HYDROXY SILANES, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME
#22COMPOSITIONS AND METHODS FOR TREATING POMPE DISEASE
#23FORMULATIONS FOR ADMINISTERING LAAM, norLAAM AND dinorLAAM AND METHODS OF THEIR USE TO TREAT OPIOID USE DISORDER
#24FORMULATION FOR TREATING URINARY SYSTEM DISORDERS
#25POLYSULFIDE MICROPARTICLES AND USES THEREOF
#26PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PREPARATION METHOD THEREFOR
#27TAMPER RESISTANT DOSAGE FORMS
#28HIGH DOSAGE INJECTABLE BEVACIZUMAB FORMULATIONS AND METHODS
#29DELIVERY OF DISSOCIATED ISLETS CELLS WITHIN MICROPOROUS ANNEALED PARTICLE SCAFFOLD TO TREAT TYPE 1 DIABETES
#30METHOD FOR PRESERVING SOLID COMPOSITION CONTAINING FORM II CRYSTAL OF REDUCED COENZYME Q10, AND PACKAGE BODY CONTAINING SAID SOLID COMPOSITION
#31NANOFIBER MICROSPHERES AND METHODS OS USE THEREOF
#32FLEXIBLE INTERCONNECTED MICROPARTICLES ARRAYS: DEVICES, METHODS, COMPOSITIONS AND APPLICATIONS
#33DRUG DELIVERY COMPOSITION AND METHOD OF FABRICATION
#34LYOPHILIZED FORMULATIONS OF TEGAVIVINT
#35MODULAR BIOMATERIAL PLATFORM LOCAL, INJECTABLE DELIVERY OF A DRUG AND METHODS OF MAKING AND USING SAME
#36PHARMACEUTICAL FORMULATIONS COMPRISING 3-({[(4R)-7-{METHYL[4-(PROPAN-2-YL)PHENYL]AMINO}-3,4-DIHYDRO-2H-1-BENZOPYRAN-4-YL]METHYL}AMINO)PYRIDINE-4-CARBOXYLIC ACID
#37TACROLIMUS FOR IMPROVED TREATMENT OF TRANSPLANT PATIENTS
#38POLYMER COMPOUNDS AND COMPOSITION FOR NUCLEIC ACID DELIVERY COMPRISING THE SAME
#39COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#40MICROPARTICLE FORMULATIONS FOR INTRAVENOUS THERAPY AND METHODS FOR THEIR MANUFACTURE AND USE
#41ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF
#42POLYALKYLENE OXIDE PARTICLES FOR PHARMACEUTICAL FORMULATION, MEDICINAL COMPOSITION, COMPOSITION FOR PHARMACEUTICAL FORMULATION, AND PHARMACEUTICAL FORMULATION
#43PHARMACEUTICAL COMPOSITIONS
#44COMPOSITIONS CONTAINING FEXOFENADINE
#45Tamper resistant dosage forms
#46TAMPER RESISTANT DOSAGE FORMS
#47TRADITIONAL CHINESE MEDICINE COMPOSITION FOR EYEBROW ENHANCEMENT, EYEBROW GROWTH POWDER, PREPARATION METHOD AND USE THEREOF
#48Aqueous Composition Comprising Avermectins
#49GRANULES COMPRISING PROGERININ, AND SACHETS USING SAME
#50MULTIPARTICULATE ALBACONAZOLE COMPOSITION
#51DIRECT TABLETING AUXILIARY COMPOSITION
#52ANTI-INFLAMMATORY VISCOSUPPLEMENTATION AGENT CONTAINING HYALURONIC ACID
#53MICROPOROUS ANNEALED PARTICLE GEL SYSTEM
#54TAMPER RESISTANT DOSAGE FORMS
#55PHARMACEUTICAL COMPOSITIONS
#56HIGH-DOSE COMPRESSIBLE DOSAGE FORMS MANUFACTURED BY SIMULTANEOUS MELT-COATING AND MELT-GRANULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS
#57Pharmaceutical compositions
#58FORMULATION WITH IMPROVED BIOAVAILABILITY
#59AMORPHOUS DISPERSION OF FERRIC MALTOL AND THE PREPARATION PROCESS THEREOF
#60GRANULATE COMPOSITION COMPRISING NILOTINIB
#61BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
#62COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF
#63FORMULATIONS OF TEGAVIVINT
#64METHODS, COMPOSITIONS, AND DEVICES FOR DRUG / LIVE CELL MICROARRAYS
#65Tamper resistant dosage forms
#66METHOD FOR THE PRODUCTION OF PRECISELY SIZED MACRO- AND MICRO-ELP CONTAINING PARTICLES FOR THE DELIVERY OF THERAPEUTIC AGENTS
#6713C METHACETIN GRANULE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#68POLYMER PROTEIN MICROPARTICLES
#69Pharmaceutical compositions
#70FORMULATION AND METHOD FOR TREATMENT OF URINARY SYSTEM DISORDERS
#71TUMOR VACCINE BASED ON TUMOR-DERIVED MICROPARTICLES, AND PREPARATION METHOD AND USE THEREOF
#72FREEZE DRIED DRUG NANOSUSPENSIONS
#73A DISPERSIBLE EXTENDED RELEASE COMPOSITION, AND A PROCESS FOR PREPARING THE SAME
#74FORMULATIONS OF CANNABINOIDS
#75METHOD FOR THE PRODUCTION OF PRECISELY SIZED MACRO- AND MICRO-ELP CONTAINING PARTICLES FOR THE DELIVERY OF THERAPEUTIC AGENTS
#76Compounds and compositions for intracellular delivery of therapeutic agents
#77Amorphous solid dispersions
#78Tamper resistant dosage forms
#79LONG-ACTING INJECTABLE FORMULATIONS OF KETAMINE PAMOATE SALTS
#80Thermoplastic Elastomer De-Tackifier Additive and Compounds
#81NOVEL COMPOSITIONS BASED ON POLYINOSINIC-POLYCYTIDYLIC ACID
#82NOVEL COMPOSITIONS BASED ON POLYINOSINIC-POLYCYTIDYLIC ACID
#83PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF AND DUTASTERIDE OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF EXHIBITING NOVEL DISSOLUTION RATE
#84Lyophilized formulations of tegavivint
#85READILY DISPERSIBLE SHELF-STABLE MICROBIAL GRANULES
#86WATER-SOLUBLE CANNABINOID FORMULATION AND PREPARATION METHOD THEREFOR
#87CALCIUM SUCCINATE MONOHYDRATE FORMULATION
#88AGGREGATING MICROPARTICLES FOR MEDICAL THERAPY
#89LONG-ACTING BUPIVACAINE MICROSPHERE FORMULATIONS
#90LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME
#91COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION
#92AMORPHOUS SOLID DISPERSIONS
#93TREATMENT OR PREVENTION OF A DISEASE OR DISORDER
#94CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES
#95PHARMACEUTICALLY ACTIVE COMPOUND FORMULATIONS
#96COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#97CHOLESTANE DERIVATIVES, PREPARATIONS CONTAINING THESE DERIVATIVES AND USE THEREOF
#98MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE
#99Pharmaceutical composition and use thereof
#100Stable Formulations of Linaclotide
#101POWDER SOLID COMPOSITIONS, PROCESS FOR THEIR PREPARATION, FORMULATIONS AND USE THEREOF
#102MODIFIED ADENOSINE NUCLEOSIDE FOR USE IN THE TREATMENT OF VIRAL INFECTIONS
#103SILK PARTICLES ENCAPSULATING OXYGEN CARRIERS AS ARTIFICIAL BLOOD SUBSTITUTE
#104Formulated Cannabis Oil Powder By Nanoemulsifycation, Methods Of Producing And Uses Thereof
#105Pharmaceutical Composition Containing Dabigatran Etexilate And Preparation Method Thereof
#106BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
#107Tamper resistant dosage forms
#108Lyophilized Formulations of AAV Drug Products
#109ARTIFICIAL ANTIGEN PRESENTING CELL SYSTEM AND USES THEREOF
#110NOVEL POLYURETHANES AND THEIR USE IN PHARMACEUTICAL DOSAGE FORMS
#111Tamper resistant dosage forms
#112Hydrophilic Degradable Microsphere for Delivering Travoprost
#113IMPLANTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#114CHEMICAL COMPOSITION
#115Continuous release compositions made from hyaluronic acid, and therapeutic applications of same
#116CROSSLINKED PARTICLES
#117Formulations of tegavivint
#118COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION
#119METHODS FOR CONSOLIDATING ANTIBIOTIC-ELUTING POLYMERIC MATERIALS
#120INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES
#121Uses and Formulations of Cannabinoids
#122Twin-screw dry granulation for producing solid formulations
#123TUNING OF RELEASE KINETICS IN HYDROGELS
#124LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF
#125Tamper resistant dosage forms
#126GASTRO-RETENTIVE DRUG DELIVERY SYSTEM
#127COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH
#128PHARMACEUTICAL COMPOSITION COMPRISING SUSTAINED-RELEASE MICROSPHERES INCLUDING GLP-1 ANALOGUE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#129Extended release, abuse deterrent dosage forms
#130DRUG DELIVERY SYSTEMS AND TARGETED RELEASE OF PHARMACEUTICAL AGENTS WITH FOCUSED ULTRASOUND
#131NANOFORMULATION WITH DIVERSE FUNCTIONAL MOLECULES FROM TURMERIC AND PROCESS FOR PREPARATION OF THE SAME
#132JNK INHIBITORS AS ANTICANCER AGENTS
#133Freeze dried drug nanosuspensions
#134SOLID FORMS OF OMECAMTIV MECARBIL DIHYDROCHLORIDE AND PROCESSES THEREOF
#135REHYDRATABLE, MORPHOLOGICALLY DIVERSE NANOCARRIER POWDERS
#136COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#137Microporous annealed particle gel system
#138NANOPARTICLE ISOFLAVONE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#139FULVESTRANT PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#140BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS
#141In vivo bulking agent, injection comprising same, and preparation method therefor
#142Lipid nanoparticle compositions and methods of formulating the same
#143CORONAVIRUS RNA VACCINES
#144COMPOSITION WITH DRUG MICRO-NANO PARTICLES OF AN ANTI-CANCER AGENT
#145Amorphous solid dispersions
#146ORAL DELIVERY SYSTEM
#147Pharmaceutical compositions
#148INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#149A STABLE LYOPHILIZED FORMULATION FOR HYBRID FC FUSED G-CSF
#150Lipid nanoparticle compositions and methods of formulating the same
#151MICRONIZED DRUG RESINATE-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREPARATION THEREOF
#152Polymer excipients for drug delivery applications
#153Polymer protein microparticles
#154DICLOFENAC SACHET COMPOSITION
#155Stable Formulations of Linaclotide
#156METHOD, COMPOSITION AND PACKAGE FOR BOWEL CLEANSING
#157Antiviral prodrugs and nanoformulations thereof
#158COMPOSITIONS COMPRISING A TWEAK LIGAND AND METHODS OF USING SAME
#159Amorphous solid dispersions
#160Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
#161Tacrolimus for improved treatment of transplant patients
#162PHARMACEUTICAL COMPOSITIONS COMPRISING OTIC THERAPEUTIC AGENTS AND RELATED METHODS
#163Pharmaceutical compositions of pimobendan
#164Tablet dosage formulations of oleyl phosphocholine
#165FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
#166Pharmaceutical compositions
#167Pharmaceutical compositions
#168Lyophilized formulations of tegavivint
#169Lyophilized formulations of tegavivint
#170Lyophilized formulations of tegavivint
#171PHARMACEUTICAL DOSAGE FORM OF COLESTIPOL
#172Sustained delivery of therapeutic agents to an eye compartment
#173Pharmaceutical compositions
#174INJECTABLE SUSTAINED-RELEASE FORMULATIONS FOR TREATMENT OF JOINT PAIN AND INFLAMMATION
#175Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
#176Bendamustine pharmaceutical compositions
#177COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE
#178EXTENDED RELEASE FORMULATIONS OF HUMAN CHORIONIC GONADOTROPIN (HCG)
#179Duloxetine sprinkles
#180Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
#181ENHANCED THERAPEUTIC USAGE OF A PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCELOSIDE HYDROLASE PRODRUG
#182Solid Pharmaceutical Formulation of PARP Inhibitors and Use Thereof
#183Poly(2-oxazoline)s and methods for preparing them
#184Novel formulation of metaxalone
#185Powder for oral suspension containing lamotrigine
#186Poly(diaminosulfide) particle-based vaccine
#187Compositions comprising PGI2-receptor agonists and processes for the preparation thereof
#188SOLID COMPOSITIONS OF ACTIVES, PROCESSES FOR PREPARING SAME AND USES OF SUCH SOLID COMPOSITIONS
#189NANOPARTICLE/HYDROGEL COMPLEXT FOR DRUG CARRIER
#190SOLID DISPERSION OF RIFAMYCIN-NITROIMIDAZOLE COUPLING MOLECULE AND APPLICATION THEREOF
#191Antiviral prodrugs and nanoformulations thereof
#192THERAPEUTIC NANOPARTICLES BY COACERVATE COMPLEXATION AND THEIR USE FOR TREATING BACTERIA
#193LOADABLE POLYMERIC PARTICLES FOR THERAPEUTIC AND/OR DIAGNOSTIC APPLICATIONS AND METHODS OF PREPARING AND USING THE SAME
#194Gastro-resistant formulation containing posaconazole
#195HYDROPHOBICITY/HYDROPHILICITY-TUNABLE ORGANOSILOXANE NANO-/MICROSPHERES AND PROCESS TO MAKE THEM
#196Antiviral prodrugs and nanoformulations thereof
#197COMPOSITIONS AND METHODS OF TREATMENT
#198Methods, compositions, and devices for making sustained biodegradable implants in tissue
#199NANOPARTICLE FORMULATIONS OF IKE AND METHODS OF USE THEREOF
#200DRUG COMPOSITIONS
#201Method for synthesizing a new ferrihydrite nano-photosensitizer and its antibacterial and anticancer use
#202Naltrexone Long Acting Formulations and Methods of Use
#203Compositions and methods for treating Pompe disease
#204Enzymes Entrapped in Organopolysiloxane Matrix for Treating Intestinal Diseases
#205CORONAVIRUS RNA VACCINES
#206Device And Kit For Dosing And Dispensing Non-Liquid Medicine
#207Nanoparticles for crossing the blood brain barrier and methods of treatment using the same
#208Polymer excipients for drug delivery applications
#209Antiviral prodrugs and nanoformulations thereof
#210Nanofiber segments and methods of use thereof
#211DRUG-CONTAINING PARTICLE
#212PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO
#213POWDER COATING COMPOSITIONS FOR COATING PHARMACEUTICAL PELLETS
#214Drug delivery composition and method of fabrication
#215TAMPER RESISTANT DOSAGE FORMS
#216Ophthalmic Delivery Device And Ophthalmic Active Agent Containing Compositions
#217Implantable isoxazoline pharmaceutical compositions and uses thereof
#218GRANULATION COMPOSITION
#219Method for preserving biopharmaceuticals
#220CYTOTOXIC LIPID PARTICLES TARGETED TO TUMOR-ASSOCIATED MYELOID CELLS (TAMCS) AND SYNERGIZED WITH RADIATION THERAPY FOR TREATING GLIOBLASTOMA
#221INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES
#222Compositions, methods and devices for forming implants from injected liquids
#223Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[Nā²-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide
#22417-hydroxyprogesterone ester-containing oral compositions and related methods
#225Duloxetine sprinkles
#226Pharmaceutical compositions
#227Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
#228COMPOSITION AND METHOD FOR FREEZE-DRYING PHARMACEUTICAL COMPOSITION CONTAINING ANIONIC DRUG
#229Spray drying process with continuous preparation of spray solution
#230PHARMACEUTICAL COMPOSITION CONTAINING RESIN PARTICLES
#231Formulated cannabis oil powder by nanoemulsification, methods of producing and uses thereof
#232Pharmaceutical compositions of pimobendan
#233COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#234Tacrolimus for improved treatment of transplant patients
#235Tacrolimus for improved treatment of transplant patients
#236PHARMACEUTICAL ABUSE DETERRENT COMPOSITION CONSTRUCTED IN MORE THAN ONE STRENGTHS
#237PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS
#238Compositions and methods for treating vaginal dryness
#239Continuous release compositions made from hyaluronic acid, and therapeutic applications of same
#240BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
#241Compositions for stabilizing and delivering proteins
#242Tamper resistant dosage forms
#243Tamper resistant dosage forms
#244Tamper resistant dosage forms
#245Method, composition and package for bowel cleansing
#246CONTROLLED RELEASE FORMULATIONS FOR THE INDUCTION AND PROLIFERATION OF BLOOD CELLS
#247FORMULATIONS OF RIFAXIMIN AND USES THEREOF
#248Composition and method for treating osteoarthritis with manganese dioxide nanoparticles
#249LIPID NANOPARTICLES CONTAINING PHARMACEUTICAL AND/OR NUTRACEUTICAL AGENTS AND METHODS THEREOF
#250AMORPHOUS ONAPRISTONE COMPOSITIONS AND METHODS OF MAKING THE SAME
#251Oral Formulations And Uses Thereof
#252Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules
#253Twin-screw dry granulation for producing solid formulations
#254TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#255Ophthalmic delivery device and ophthalmic drug compositions
#256INTRANASAL PHARMACEUTICAL COMPOSITION COMPRISING ANTICANCER DRUGCONTAINING NANOPARTICLES FOR TREATING BRAIN DISEASES
#257Novel formulation of metaxalone
#258Microporous annealed particle gels and methods of use
#259Solid dispersions comprising tacrolimus
#260TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#261Method for modifying release of a therapeutically active agent from an elastomeric matrix
#262Process for the preparation of a freeze-dried pharmaceutical composition containing mitomycin C
#263POLYDOPAMINE-ENCAPSULATED NANODIAMONDS AND METHODS
#264Pharmaceutical JAK kinase inhibitor and diethylene glycol composition for topical administration and preparation method therefor
#265TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#266Extended release, abuse deterrent dosage forms
#267LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF
#268Pharmaceutical compositions
#269HSP90 TARGETED CONJUGATES AND PARTICLE FORMULATIONS THEREOF
#270Method of making an in situ sustained biodegradable drug delivery implant by filling an artificial tissue cavity
#271ACUTE AND CHRONIC MITOCHONDRIAL ELECTRON TRANSPORT CHAIN DYSFUNCTION TREATMENTS AND GRAPHENIC MATERIALS FOR USE THEREOF
#272NANOPARTICULATE FORMULATION COMPRISING AN mPGES-1 INHIBITOR
#273DIHYDROMYRICETIN NANOPARTICLE FORMULATIONS
#274PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(EPSILON-CAPROLACTONE) AND POLYETHYLENE OXIDE
#275Bubblyte
#276Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists
#277Pharmaceutical formulation containing gelling agent
#278Compounds and compositions for intracellular delivery of therapeutic agents
#279Methods for forming implants from injected thermoreversible gels
#280Sustained Release Nitric Oxide in Intestinal Tract
#281PHARMACEUTICAL COMPOSITION CONTAINING CELECOXIB
#282Duloxetine sprinkles
#283COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION
#284PHARMACEUTICAL FORMULATIONS OF SUVOREXANT
#285PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#286Powder solid compositions, process for their preparation, formulations and use thereof
#287DRUG DELIVERY SYSTEM FOR TREATMENT OF CANCER
#288Drug delivery composition and method of fabrication
#289Prodrug compositions
#290COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH
#291Tuning of release kinetics in hydrogels
#292Stable formulations of linaclotide
#293TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#294PHARMACEUTICAL COMBINATION COMPOSITION COMPRISING COMPLEX FORMULATIONS OF IVACAFTOR AND LUMACAFTOR AND THEIR SALTS AND DERIVATIVES, PROCESS FOR THEIR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#295Stable Formulations of Linaclotide
#296TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#297Aggregating microparticles for medical therapy
#298Aggregating microparticles for medical therapy
#299Amorphous solid dispersions
#300Drug compositions